KMS-12-BM (Q54900168)

23 January 2023

1 reference

23 January 2023

1 reference

Two human myeloma cell lines, amylase-producing KMS-12-PE and amylase-non-producing KMS-12-BM, were established from a patient, having the same chromosome marker, t(11;14)(q13;q32).

23 January 2023

1 reference

23 January 2023

Establishment and characterization of five human myeloma cell lines

1 reference

23 January 2023

Establishment of five human myeloma cell lines

1 reference

23 January 2023

Screening the p53 status of human cell lines using a yeast functional assay

1 reference

23 January 2023

Malignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia

1 reference

23 January 2023

Cellular biological differences between human myeloma cell lines KMS-12-PE and KMS-12-BM established from a single patient.

1 reference

23 January 2023

Overexpression of PDZK1 within the 1q12-q22 amplicon is likely to be associated with drug-resistance phenotype in multiple myeloma

1 reference

23 January 2023

The phenotype of normal, reactive and malignant plasma cells. Identification of "many and multiple myelomas" and of new targets for myeloma therapy

1 reference

23 January 2023

Molecular characterization of human multiple myeloma cell lines by integrative genomics: insights into the biology of the disease.

1 reference

23 January 2023

Characterization of MYC translocations in multiple myeloma cell lines

1 reference

23 January 2023

An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma

1 reference

23 January 2023

Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles.

1 reference

23 January 2023

A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines

1 reference

23 January 2023

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

1 reference

23 January 2023

A comprehensive transcriptional portrait of human cancer cell lines

1 reference

23 January 2023

Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies

1 reference

23 January 2023

A landscape of pharmacogenomic interactions in cancer.

1 reference

23 January 2023

Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays

1 reference

23 January 2023

Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines.

1 reference

23 January 2023

Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.

1 reference

23 January 2023

Addiction to c-MYC in multiple myeloma

1 reference

23 January 2023

A simple flow cytometry-based barcode for routine authentication of multiple myeloma and mantle cell lymphoma cell lines.

1 reference

23 January 2023

Profiling the B/T cell receptor repertoire of lymphocyte derived cell lines

1 reference

23 January 2023

An Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines

1 reference

23 January 2023

Next-generation characterization of the Cancer Cell Line Encyclopedia

1 reference

23 January 2023

The LL-100 panel: 100 cell lines for blood cancer studies.

1 reference

23 January 2023

Quantitative Proteomics of the Cancer Cell Line Encyclopedia.

1 reference

23 January 2023

Evaluating the efficacy of multiple myeloma cell lines as models for patient tumors via transcriptomic correlation analysis

1 reference

23 January 2023

established from medical condition

multiple myeloma

1 reference

23 January 2023

derived from organism type

1 reference

http://purl.obolibrary.org/obo/EFO_0006612

23 January 2023

1 reference

23 January 2023

http://purl.obolibrary.org/obo/BTO_0006459

1 reference

23 January 2023

Identifiers

1 reference

23 January 2023